# 1. Financial Performance ## A. Key Figures * Revenue: ₹303 Cr Q3 FY'26 (-31.7% YoY) * Normalized PAT: ₹138 million (-18.6% YoY) · PAT Margin +73 bps YoY * Normalized EBITDA: ₹309 Mn (10.2% margin, +207 bps YoY) * **Reported EBITDA:** **₹275 Mn** (9.1% of revenue) * **Reported PAT:** **₹112 million** (3.7% of revenue) ## B. Revenue Trends * **Softness Explained:** Q3 revenue decline attributed to customer-specific holiday-period delays and tariff-related uncertainty prompting inventory caution. * **Base Effect:** Year-on-year comparison pressured by completion of a large cyclical order in prior year, now lapping into easier comps. * **Profitability Resilience:** Despite lower top line, normalized profitability improved significantly, reflecting structural cost and mix benefits. ## C. Margin Expansion * **Structural Margin Improvement:** Normalized EBITDA margin expanded over 200 bps YoY, driven by favorable revenue mix, supply chain gains, and operational efficiency. * **Future Margin Trajectory:** Newly booked orders carry **higher-margin profiles**, with management confident backlog will yield **equal or better margins** than current levels. * **Growth Levers:** Margin expansion in FY'27 expected to be fueled by shift to **build-to-spec (B2S) projects** and improved industry mix, enhancing operating leverage. * **Near-Term Outlook:** Q4 margins expected to be **slightly higher than Q3**, with double-digit EBITDA margins sustainable amid sales and tech investments. ## D. Balance Sheet * **Capital Allocation:** As of Dec-25, **2% of IPO proceeds** used for working capital, **4% for capex**; remainder to be deployed as planned. * **M&A Activity:** **₹78 Cr** spent on an international deal that was terminated; company remains active in evaluating inorganic opportunities. * **Financial Flexibility:** Maintains **net cash-positive balance sheet** with capacity to leverage **₹350–400 Cr** for growth initiatives. ## E. Cash Flow * **Working Capital Dynamics:** DIO elevated due to shipment delays and pre-Q4 inventory build; expected to normalize by year-end. * **Net Working Capital:** Temporary slippage in Q3 offset by higher DPO from supply chain efficiency; improvement expected by Q4 close. * **Cash Flow Outlook:** Despite near-term pressures, company expects **strong net positive cash flow for the full year**. --- # 2. Order Book & Demand ## A. Key Figures * **Order Intake:** **₹387 Cr** (Q3) · **₹500 Cr** (expected Q4 run rate) * **Order Book:** **₹2,350 Cr** (Q3) (+₹583 Cr QoQ) · **₹2,400 Cr** (current, ~) * Book-to-Bill Ratio: **1.56 (YTD)** · **1.3 (Q3)** · **>1 (3 consecutive quarters)** ## B. Demand Drivers & Market Positioning * **Structural Growth Tailwinds:** Electrification and digitization are accelerating across transportation, industrial, energy, and consumer sectors, boosting demand for **high-reliability electronics manufacturing**. * **Domestic Momentum:** India’s expanding defense, rail, and manufacturing investments are fueling **strong medium-term visibility**, with aerospace, industrial, and medical driving the India-led order ramp. * **Commercial Resilience:** Sustained book-to-bill above 1 reflects effective strategy and **robust underlying demand**, independent of near-shoring or Altek-related activity. ## C. Order Quality & Visibility * **High-Value Program Shift:** Improved order book quality driven by focus on **lucrative, long-duration programs**, supporting double-digit EBITDA margins and business model resilience. * **Revenue Visibility:** Build-to-spec and NPA engagements ensure **predictable revenue flow**, with Q4 revenue recovery on track and strategic deals progressing toward conversion. --- # 3. Product & Segment Mix ## A. Key Figures * **B2S Revenue Mix:** **6–7%** FY'26 (up from prior) · **>10%** expected FY'27 ## B. B2S Revenue Share * **Strategic Scale-Up:** B2S has transitioned to a mainstream business with **first revenue recognized**, supported by investments in talent, technology, and integrated platform capabilities to drive design-led growth. * **Growth Trajectory:** B2S mix on track for **double-digit contribution in FY'27**, with management signaling strong scalability and margin accretion potential. * **Altek Performance:** Altek division delivering **healthy and profitable** results, though no granular financials disclosed. ## C. PCBA Dominance * **Core Strength, Expanding Stack:** PCBA remains the dominant segment, while **cables and sheet metal capabilities** are being scaled to offer more integrated solutions and enhance resilience. * **Diversifying Value-Add:** Box build, mechanical, and other services are growing steadily, supporting **margin expansion and reduced concentration risk**. ## D. Vertical Diversification * **Strategic Expansion Beyond A&D:** Clear roadmap to broaden exposure into **industrial, medical, and automotive** verticals over the next 2–3 years, reducing reliance on aerospace and defense. * **Balanced Industry Mix:** Post-large defense order, revenue mix has rebalanced with rising contributions from **aerospace, industrial, and medical** segments, aided by operational upgrades. * **Defense Ambitions:** On-ground presence and certification pursuits underway to capture **larger, complex global defense programs**, reinforcing long-term positioning. * **Growth Outlook by Vertical:** Revenue growth expected to be **broadly balanced across sectors**, with only a slight tilt toward aerospace and defense. --- # 4. Manufacturing & Capacity ## A. Operational Model & Scale * **Headline:** Operates **7 global PCBA lines** with integrated box build; high-mix, low-volume complexity renders asset productivity metrics irrelevant. * **Headline:** U.S. production shift underway to mitigate **50% tariff risk** on India-origin shipments, though revenue exposure remains undisclosed. ## B. Manufacturing Excellence & Capex * **Headline:** Recognized as **Best Performer in Electronic Hardware Exports (STPI FY '24–'25)**, underscoring quality and delivery reliability. * **Headline:** Sustained focus on **automation, digitization, and MES adoption** to boost efficiency, traceability, and cost competitiveness across regulated end markets. * **Headline:** Regular capex expected at **1–2% of revenues**, with incremental capacity investments funded via financial flexibility for strategic customer needs. --- # 5. Sales & Customer Expansion ## A. New Customer Wins * **Headline:** Recent customer acquisition strategy is proving effective, with a significant portion of new orders coming from clients onboarded within the past year. * **Headline:** Added **2 new customers** this quarter—expanding into medical (battery management) and industrial (motor controls)—demonstrating sectoral diversification. * **Headline:** Order book growth driven by both new customer wins and portfolio deepening, with sustained momentum over the last three quarters. * **Headline:** Strategic focus on Europe includes inorganic opportunities, targeting demand for reliable partners in a high-potential region. ## B. Strategic Account Growth * **Headline:** Evolving from vendor to **strategic collaborator**, with customers engaging Cyient DLM in redesigns and new product launches across the full life cycle. * **Headline:** Sales pipeline strengthening, supported by deeper customer engagement and a rising share of opportunities originating in India. * **Headline:** **4 anchor customers** (2 transportation, 1 industrial, 1 defense) co-developing next-gen products, with revenue ramp expected within 2 years and meaningful contribution from FY '28. * **Headline:** Rest of World remains top revenue contributor, though India’s share is on a gradual upward trajectory. ## C. Sales Team Build * **Headline:** Sales engine being scaled in India and key international markets, with strategic hires largely onboarded or joining by year-end. * **Headline:** Expanded team expected to drive future order inflow, though full impact anticipated only after **at least two quarters** of ramp-up. * **Headline:** Go-to-market strategy emphasizes cross-functional alignment to capture large, multiyear programs—early traction already evident. --- # 6. Risks & Tariff Exposure ## A. Key Figures * **B. S. Revenue Exposure:** **40%** of total revenue * **Tariff Rate:** **50%** applied to certain U.S.-bound shipments * **Q3 Tariff Impact:** Minimal, affecting only a **small portion** of shipments ## B. U.S. Tariff Impact * **Mitigation Underway:** Four strategic options—包括 rerouting and production shifts—are active and effectively reducing tariff burdens for customers. * **Customer Confidence Restored:** Initial order delays due to tariff concerns have eased following implementation of mitigation solutions. * **Limited Near-Term Disruption:** Q3 saw minimal shipment deferrals, with most U.S. operations resuming under revised trade structures. ## C. Geopolitical Shifts * **Strategic Beneficiary:** Rising global defense spending and supply chain derisking are expanding opportunities in high-complexity aerospace and defense programs. * **India Advantage:** Geopolitical realignments position India as a preferred alternative manufacturing hub, elevating the scale and quality of awarded programs. * **Recognition of Excellence:** Received a **risk mitigation award** from a key aerospace client, validating proactive safety and reliability practices. --- # 7. Guidance & Outlook ## A. Key Figures * **FY '27 Revenue Growth:** **20% to 25%** expected (confirmed) · **slightly double-digit** growth projected ## B. FY '27 Growth View * **Confident Growth Trajectory:** Strong outlook underpinned by AI-driven demand in data centers, edge, and industrial automation, with strategic positioning in high-growth segments. * **Growth Catalysts:** Expansion fueled by **B2S ramp-up**, new wins in **EV and industrial**, and potential **M&A contribution**, with B2S programs setting foundation for **stronger growth and margin expansion from FY '28**. * **Market Tailwinds:** Robust ESDM industry dynamics and **growing India momentum** provide strong demand visibility and competitive advantage. ## C. Q4 Recovery Expectation * **Q4 Rebound Confirmed:** Delayed Q3 shipments on track for current quarter delivery, with **positive YoY and sequential growth expected**, marking a clear turnaround. * **Revenue & Margin Resilience:** Leadership confirms **worst is behind on revenue**, while **margin performance remains healthy** and poised to improve with scale. * **Operational Momentum:** Strong order backlog (three consecutive quarters of growth) and **diversified product mix** support near-term recovery and long-term margin expansion. * **Working Capital Normalization:** **Elevated inventory levels** to normalize in Q4, alleviating near-term pressure on net working capital.